
1. j antimicrob chemother. 2012 feb;67(2):367-74. doi: 10.1093/jac/dkr464. epub 2011
nov 14.

molecular surveillance drug-resistant plasmodium vivax using pvdhfr, pvdhps
and pvmdr1 markers nouakchott, mauritania.

mint lekweiry k(1), ould mohamed salem boukhary a, gaillard t, wurtz n, bogreau
h, hafid je, trape jf, bouchiba h, ould ahmedou salem ms, pradines b, rogier c,
basco lk, briolant s.

author information: 
(1)laboratoire de biotechnologies, faculté des sciences et techniques, université
de nouakchott, mauritania.

objectives: plasmodium falciparum plasmodium vivax occur mauritania.
drug-resistant p. falciparum reported, drug-resistance status of
p. vivax unknown. aims present study determine the
prevalence mutant pvdhfr, pvdhps pvmdr1 genes pvmdr1 gene
amplification p. vivax isolates nouakchott, capital city mauritania,
and establish baseline molecular surveillance drug-resistant p. vivax
in country.
patients methods: 2007 2009, 439 febrile patients screened
for malaria nouakchott. sequences pvdhfr, pvdhps pvmdr1 markers 
110 p. vivax isolates determined direct sequencing pcr products. the
pvmdr1 gene copy number determined real-time pcr.
results: majority isolates successful pcr amplification (76/86,
88%) characterized wild-type pvdhfr genotype, the
remaining 10 isolates carried s58r s117n double mutations. isolates
had wild-type pvdhps genotype sakav. pvmdr1, 75 103 (73%) the
wild-type y976, 28 (27%) carried mutant f976. (98%) carried the
mutant l1076 codon. 105 isolates, 102 (97%) one copy 3 (3%) two
copies pvmdr1 gene.
conclusions: prevalence mutations associated antifolate resistance is
low mauritania. studies required determine roles pvmdr1 
mutations gene amplification conferring drug resistance. data will
serve baseline monitoring drug-resistant malaria.

doi: 10.1093/jac/dkr464 
pmid: 22086859  [indexed medline]

